{"id":"NCT06060457","sponsor":"ModernaTX, Inc.","briefTitle":"A Study to Evaluate the Safety and Immune Response of mRNA-1345, a Vaccine Targeting Respiratory Syncytial Virus (RSV), When Co-administered With a Fluzone HD, in Adults ≥65 Years of Age","officialTitle":"A Phase 3, Randomized, Observer-Blind Study to Evaluate Safety, Tolerability, and Immunogenicity of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, When Coadministered With a High-Dose, Quadrivalent Seasonal Influenza Vaccine in Adults ≥65 Years of Age","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2023-09-25","primaryCompletion":"2024-06-07","completion":"2024-06-07","firstPosted":"2023-09-29","resultsPosted":"2025-07-30","lastUpdate":"2025-07-30"},"enrollment":1900,"design":{"allocation":"RANDOMIZED","model":"SEQUENTIAL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Respiratory Syncytial Virus"],"interventions":[{"type":"BIOLOGICAL","name":"Placebo","otherNames":[]},{"type":"BIOLOGICAL","name":"mRNA-1345","otherNames":[]},{"type":"BIOLOGICAL","name":"Fluzone HD","otherNames":[]}],"arms":[{"label":"Fluzone HD + mRNA-1345","type":"EXPERIMENTAL"},{"label":"Fluzone HD Followed by mRNA-1345","type":"EXPERIMENTAL"}],"summary":"The main purpose of this study is to evaluate the safety and immunogenicity of mRNA-1345 RSV vaccine when coadministered with a high dose (HD) quadrivalent seasonal influenza vaccine (Fluzone HD) in adults ≥65 years of age. The study will examine the impact of Fluzone HD on the immune response to mRNA-1345 against RSV-A and RSV-B, as well as the impact of mRNA-1345 on the immune response to Fluzone HD against 4 vaccine-matched Influenza A and B strains.","primaryOutcome":{"measure":"Number of Participants With Solicited Local and Systemic Adverse Reactions (ARs) Within 7 Days After Day 1 Injection","timeFrame":"Within 7 days after Day 1 injection","effectByArm":[{"arm":"Fluzone HD + mRNA-1345 Followed by Placebo","deltaMin":689,"sd":null},{"arm":"Fluzone HD + Placebo Followed by mRNA-1345","deltaMin":547,"sd":null}],"pValues":[]},"eligibility":{"minAge":"65 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":2,"exclusionCount":6},"locations":{"siteCount":34,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":23,"n":947},"commonTop":[]}}